DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Implantable Cardiac Monitors Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Asia Pacific Implantable Cardiac Monitors Market is expected to witness market growth of 8.9% CAGR during the forecast period (2017-2023).
The implantable cardiac monitors market is witnessing moderated growth owing to the technological advancements in cardiac monitor devices, amplifying demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation. Additionally, Favorable reimbursement policies and prominent market players operating in the region are the factors that are further supporting the implantable cardiac monitor market growth.
Based on indication, the market report segments the market into Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on countries, the Implantable Cardiac Monitors market segments the market into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Key Topics Covered
1. Market Scope & Methodology
2. Market Overview
3. Asia Pacific Implantable Cardiac Monitors Market
4. Asia Pacific Implantable Cardiac Monitors Market by End-user
5. Asia Pacific Implantable Cardiac Monitors Market by Country
6. Company Profiles
- Abiomed, Inc.
- Abbott Laboratories
- Boston Scientific Corporation
- Reliant Heart, Inc.
- Astellas Pharma inc.
- Thoratec Corporation St. (Jude Medical, LLC)
- Agilent Technologies, Inc.
- Berlin Heart GmbH
- Schiller AG
- Jarvik Heart, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/58x4xd/asia_pacific?w=4